Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: DR. BOND who wrote (2821)	11/25/1997 10:40:00 PM
From: Steve Childs	Read Replies (1) \| Respond to of 23519

UK approval would be a terrific Christmas present. It would be an even better side dish for Thanksgiving! Regarding the fact that one must be "sexually stimulated" for Viagra to work, I assume this is purely physical stimulation (not mental/emotional arousal). I also wonder what constitutes 'stimulation'? If Viagra requires a few minutes of self-stroking or assisted-stroking (is that a medical term???), then Muse turns out to be the more natural choice.

To: DR. BOND who wrote (2821)	11/28/1997 11:21:00 AM
From: RT	Read Replies (1) \| Respond to of 23519

DR. BOND, Well, ANOTHER LONG week has gone by and still " NO NEWS" of a UK APPROVAL. This issue sure is beginning to cast a heavy shadow on their ability to execute. What could be causing the excessive delay? I remember reading in one of their press releases several months ago that they had hired an individual who had extensive experience in product certification in other countries. So far Iam not impressed with her results if she's been involved with this UK issue.. Has anyone heard whether the new plant has been inspected by the FDA or the overseas approval organization (Can't remember their official name). Managment had said they were supposed to have been inspected in November by the overseas organization. I hope the inspection already took place and we are merely awaiting the results. Unfortunatley we need both issues to be resolved before VIVUS WILL MAKE ANY SIGNIFICANT UPWARD MOVE. RT